Category Archives: Bad practices

Pharma gives the middle finger to patients

KEY TAKEAWAY:Gilead, which recently acquired Kite Pharma in an all cash deal, said the list price for Yescarta, which is to be administered just once to each patient, would be $373,000. The cost is supposed to make us feel good because the price is well below that of the first drug in this new class such as $475,000 for Novartis’s  Kymriah.

Continue reading

Pharma not wholly to blame for opioid epidemic

According to the Atlantic “opioid abuse is rampant in states like Ohio, where paramedics are increasingly spending time responding to overdoses and where coroners’ offices are running out of room to store bodies. In 2012, there were 793 million doses of opioids prescribed in the state, enough to supply every man, woman, and child, with 68 pills each”.  But is pharma really to blame? Continue reading

Precision targeted ads won’t work without great creative

KEY TAKEAWAY: According to STAT news “the music streaming service Pandora is helping pharma advertisers follow users around as they listen to music on different devices throughout the day”. What in hell makes anyone think that consumers want to be interrupted with a pharma ad while listening to music?

Continue reading